
Rare Diseases





June 03, 2025
Dual Immunotherapy May Improve Progression-Free Survival in Advanced Squamous Cell Carcinoma
The ASCO Post
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.



April 17, 2023
Single-Agent Pembrolizumab May Benefit Patients With Advanced Desmoplastic Melanoma
The ASCO Post

Advertisement
Recommendations
Advertisement